Abstract:Cancer therapy targets specific metabolic pathways or a single gene. This may result in low therapeutic effects due to drug selectivity and drug resistance. Recent studies revealed that the mitochondrial membrane potential and transmembrane permeability of cancerous mitochondria are differed from normal mitochondria. Thus, chemotherapy targeting cancerous mitochondria could be an innovative and competent strategy for cancer therapy. Previously, our work with a novel group of mitochondria targeting small molecules presented promising inhibitory capability toward various cancer cell lines and suppressed adenosine triphosphate (ATP) generation. Therefore, it is critical to understand the anticancer effect and targeting mechanism of these small molecules. This study investigated the inhibitory activity of mitochondria targeting small molecules with human cervical cancer cells - HeLa to further explore their therapeutic potential. HeLa cells were exposed to 10 mu M of syn-thesized compounds and presented elevation in intracellular reactive oxygen species (ROS) level, impaired mitochondrial membrane potential and upregulation of apoptosis as well as necrosis. In vivo, HeLa cell tumor-bearing BALB/c nude mice were treated with mitochondria targeting small molecules for 12 days consecu-tively. Throughout this chemotherapy study, no deleterious side effects nor the appearance of toxicity was observed. Furthermore, mitochondria targeting small molecules treated groups exhibited significant down-regulation with both tumor volume and tumor weight compared to the Doxorubicin (DOX) treated group. Thus, inhibition of mitochondrial ATP synthesis, activation of intracellular ROS production, down-regulation of mitochondrial membrane potential and upregulation of apoptosis and necrosis rates are the indications of cancer therapy. In this work, we examined the anticancer capability of four mitochondria targeting small molecules in vitro and in vivo, and demonstrated a novel therapeutic approach in cancer therapy with tremendous potential.

Novel Mitochondria-Targeted and Fluorescent DNA Alkylation Agents with Highly Selective Activity Against Cancer Cells

Novel mitochondria-targeted, nitrogen mustard-based DNA alkylation agents with near infrared fluorescence emission.

Mitochondria Targeting and Near-Infrared Fluorescence Imaging of a Novel Heptamethine Cyanine Anticancer Agent.

Novel lysosome-targeted anticancer fluorescent agents used in zebrafish and nude mouse tumour imaging

A novel nitrogen mustard functionalized tripodal AIE compound act as prodrug for fluorescent imaging and anticancer

Mitochondria targeted cancer therapy using ethidium derivatives

Synthesis, Mitochondrial Localization of Fluorescent Derivatives of Cinnamamide As Anticancer Agents.

Enrichment of novel quinazoline derivatives with high antitumor activity in mitochondria tracked by its self-fluorescence.

A Novel Fluorescent Dye Selectively Images and Kills Cancer Stem Cells by Targeting Mitochondria: Evidence from a Cell Line‑based Zebrafish Xenograft Model.

Aggregation‐induced Emission Based Fluorogens for Mitochondria‐targeted Tumor Imaging and Theranostics

A Novel Fluorescent Dye Invades Mitochondria to Selectively Kill Cancer Stem Cells Via Increased ROS Production

A novel bifunctional mitochondria-targeted anticancer agent with high selectivity for cancer cells

A Novel Tumor and Mitochondria Dual-Targeted Photosensitizer Showing Ultra-Efficient Photodynamic Anticancer Activities

Design, Synthesis and Biological Evaluation of Novel Thiazole-Derivatives As Mitochondrial Targeting Inhibitors of Cancer Cells.

Cyanine- and Rhodamine-Derived Alkynes for the Selective Targeting of Cancerous Mitochondria through Radical Thiol-Yne Coupling in Live Cells

Mitochondria-Targeted Two-Photon Fluorescent Photosensitizers for Cancer Cell Apoptosis via Spatial Selectability.

Carbon Quantum Dots with Intrinsic Mitochondrial Targeting Ability for Mitochondria-Based Theranostics.

Fluorescent Quinolinium Derivative As Novel Mitochondria Probe and Function Modulator by Targeting Mitochondrial RNA.

Mitochondria-specific Imaging in Living Cells with Two-Photon Absorption Small Molecule Containing Amino Groups

Biological Evaluation of Mitochondria Targeting Small Molecules As Potent Anticancer Drugs.

Potential Anticancer Agent for Selective Damage to Mitochondria or Lysosomes: Naphthalimide-modified Fluorescent Biomarker Half-Sandwich Iridium (III) and Ruthenium (II) Complexes